U.S. pharmaceutical giant Eli Lilly said it will sell bebtelovimab to states, hospitals and other healthcare providers starting this month, as the federal government’s supply has nearly run out. (The Wall Street Journal)
Skip to content
U.S. pharmaceutical giant Eli Lilly said it will sell bebtelovimab to states, hospitals and other healthcare providers starting this month, as the federal government’s supply has nearly run out. (The Wall Street Journal)
Talking point: The government will exhaust its supply of bebtelovimab as soon as the week of Aug. 22 and doesn’t have the funds to purchase more. Eli Lilly entered into an agreement to supply the U.S. government with an additional 150,000 doses in late June. Vancouver-based biotech AbCellera collaborated with Eli Lilly to develop the COVID-19 antibody—its second during the partnership. The first, bamlanivimab, was widely used in the U.S. but not in Canada. AbCellera earns royalties on sales of its co-developed therapies, which have significantly boosted its revenue.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
News
What to expect as the CUSMA review talks finally get underway
Briefing
Alberta to submit West Coast pipeline proposal to the federal Major Projects Office this week
Magnificent Seven lost a combined US$2.2T in market value in June
Radical Ventures, Gomez, Hinton back Etched to build hardware to run AI
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
